The Quantitative Biosciences Institute (QBI) at UCSF and the Office for Science and Technology of the Embassy of France in the United States present the "HealthAI Symposium," a French American Innovation event at the University of California, San Francisco from December 6-7, 2023. Supported by renowned research institutions, this science fair aims to bring together different actors from industry, academia and government from the United States and France to talk about AI applications for the health sciences. 

Artificial Intelligence, and even more so generative artificial intelligence has revolutionized the healthcare industry, offering an array of innovative applications that have the potential to transform patient care by driving the creation of start-ups and the emergence of new technological solutions worldwide. The applications are manifold: aid in diagnosis, analysis of exams, in particular in imaging, contribution to the discovery of new therapeutic targets and molecules, among others.

Such innovations appeal to multidisciplinary approaches which involve strengthening the interfaces between experts with very different profiles: AI specialists, data analysts, researchers in biology and health, doctors, regulators, businesses and patients. Meanwhile, these increasingly concrete developments require a reflection in terms of ethics and regulation: legal responsibility, risks potential, influence of AI on the role of the doctor, management of learning data sets, bias and discrimination.

This in-person event aims to tackle these various issues, through the prism of Franco-American cooperation, by bringing together experts of those research fields through a succession of panels and sessions, open to both specialists and the general public.  

Agenda – December 6, 2023

12:30 – 1:30 PM – Opening Lunch

1:30 – 2:30 PM – Panel 1 : Artificial Intelligence in Cell Biology
Moderated by Lisiena Hysenaj – Scientist, Translational Immunology, Parvus Therapeutics
Laurence Calzone – Research Engineer, Computational Systems Biology of Cancer, Institut Curie
Michael Keiser – Associate Professor, Institute for Neurodegenerative Diseases, UCSF
Hocine Lourdani – Group Product Manager, Deepcell
Audrey Smith – Chief Operating Officer, MLtwist

2:30 – 3:00 PM – Break & Networking

3:00 – 4:00 PM – Panel 2 : Exploring the Impact of Generative Al in Drug Discovery
Moderated by Kathy Giacomini – Dean, School of Pharmacy, UCSF
Ron Dror – Associate Professor, Computer Science, Stanford University
James Fraser – Professor and Chair, Department of Bioengineering and Therapeutic Sciences, UCSF
Julien Mamet – Chief Executive Officer, Core Biotherapeutics 

Agenda – December 7, 2023

9:00 – 9:30 AM – Light Breakfast

9:30 – 10:30 AM – Panel 3 : Generative AI in Clinical Practice
Moderated by Romain Piraccio – Professor, Anesthesia and Perioperative Medicine, UCSF
Dereck Paul – Cofounder & Chief Executive Officer, Glass Health
Valentina Pedoia – Associate Professor, Radiology, UCSF
Jean-Frédéric Petit-Nivard – Chief Commercial Officer, Owkin
Thomas Walter – Research Director, Mines Paris Tech, Institut Curie

10:30 – 11:00 AM – Break & Networking

11:00 – 12:00 PM – Panel 4 : Ethical Considerations of AI in Healthcare
Moderated by Antoine Forget – Associate Researcher, Cancer, UCSF
Hubert Etienne – Global Generative AI Ethics Lead & UX Researcher (RAI), Meta
Keolu Fox – Professor, UCSD | Co-Director/Co-Founder, Indigenous Futures Institute
Zahra Timsah – Principal of Data Transformation and Artificial Intelligence, IQVIA

12:00 – 1:00 PM – Closing Lunch & Photo Exhibition